These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28771060)

  • 1. Does double-hit follicular lymphoma with translocations of MYC and BCL2 change the definition of transformation?
    Katsushima H; Fukuhara N; Konosu-Fukaya S; Himuro M; Kitawaki Y; Ichikawa S; Ishizawa K; Sasano H; Harigae H; Ichinohasama R
    Leuk Lymphoma; 2018 Mar; 59(3):758-762. PubMed ID: 28771060
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
    Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
    Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous Involvement in a High Grade B-Cell Lymphoma With Rearrangement of MYC, BCL2, and BCL6 Transformed From Follicular Lymphoma.
    Martinez-Mera C; Herrero-Moyano M; López-Elzaurdia C; Loscertales J; Aragües M
    Am J Dermatopathol; 2019 Jan; 41(1):80-82. PubMed ID: 30608910
    [No Abstract]   [Full Text] [Related]  

  • 4. Unexpected MYC::DMD translocation after transformation of follicular lymphoma with IGH::BCL2 and IGH::MYC.
    Carlsen ED; Aarabi M; Swerdlow SH
    Br J Haematol; 2023 Oct; 203(2):e74-e77. PubMed ID: 37485649
    [No Abstract]   [Full Text] [Related]  

  • 5. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation from follicular lymphoma to high-grade B-cell lymphoma/leukemia with additional t(2;8)(p12;q24), with inverse expressions of c-MYC and BCL-2, and light-chain switch.
    Mannouji K; Tasaka T; Akiyama T; Irei I; Sano F; Matsuhashi Y; Wada H; Tohyama K; Sugihara T; Sadahira Y
    Pathol Int; 2009 Apr; 59(4):261-4. PubMed ID: 19351371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma.
    Li S; Saksena A; Desai P; Xu J; Zuo Z; Lin P; Tang G; Yin CC; Seegmiller A; Jorgensen JL; Miranda RN; Reddy NM; Bueso-Ramos C; Medeiros LJ
    Oncotarget; 2016 Jun; 7(25):38122-38132. PubMed ID: 27203548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.
    Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T
    Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma.
    Moore AM; Moshkin O; Swain GJ; Crocker S; LeBrun DP
    Diagn Pathol; 2018 May; 13(1):34. PubMed ID: 29793519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-hit lymphoma demonstrating t(6;14;18)(p25;q32;q21), suggesting two independent dual-hit translocations, MYC/BCL-2 and IRF4/BCL-2.
    Tabata R; Yasumizu R; Tabata C; Kojima M
    J Clin Exp Hematop; 2013; 53(2):141-50. PubMed ID: 23995111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
    Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
    Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Double-Hit Follicular Lymphoma with BCL2 and MYC Translocations].
    Horiuchi M; Fuseya H; Tsutsumi M; Hayashi Y; Hagihara K; Kanashima H; Nakao T; Fukushima Y; Inoue T; Yamane T
    Gan To Kagaku Ryoho; 2016 Sep; 43(9):1135-8. PubMed ID: 27628560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and prognostic significance of
    Kim M; Hwang HS; Son EM; Cho H; Yoon DH; Suh C; Park CS; Go H; Huh J
    Leuk Lymphoma; 2020 Dec; 61(14):3342-3350. PubMed ID: 32921221
    [No Abstract]   [Full Text] [Related]  

  • 14. Transformation of double-hit follicular lymphoma to plasmablastic lymphoma: a partial role of MYC gene rearrangement.
    Ise M; Kageyama H; Ikebe D; Araki A; Kumagai K; Itami M
    J Clin Exp Hematop; 2018 Sep; 58(3):128-135. PubMed ID: 30012920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC expression and translocation analyses in low-grade and transformed follicular lymphoma.
    Aukema SM; van Pel R; Nagel I; Bens S; Siebert R; Rosati S; van den Berg E; Bosga-Bouwer AG; Kibbelaar RE; Hoogendoorn M; van Imhoff GW; Kluin-Nelemans HC; Kluin PM; Nijland M
    Histopathology; 2017 Dec; 71(6):960-971. PubMed ID: 28730642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma.
    Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Niino D; Ohshima K
    Pathol Int; 2015 Sep; 65(9):486-9. PubMed ID: 26182827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-hit follicular lymphoma diagnosed due to central nervous system symptoms.
    Kawajiri-Manako C; Mishina T; Tsujimura H; Maruyama S; Sato A; Sugawara T; Kumagai K; Nakamura R; Itami M; Takeuchi M
    Ann Hematol; 2023 May; 102(5):1281-1282. PubMed ID: 36971807
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant hematopoietic cell lines: in vitro models for double-hit B-cell lymphomas.
    Drexler HG; Eberth S; Nagel S; MacLeod RA
    Leuk Lymphoma; 2016 May; 57(5):1015-20. PubMed ID: 26727417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.
    Ye Q; Xu-Monette ZY; Tzankov A; Deng L; Wang X; Manyam GC; Visco C; Montes-Moreno S; Zhang L; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Møller MB; Piris MA; Winter JN; Medeiros LJ; Hu S; Young KH
    Oncotarget; 2016 Jan; 7(3):2401-16. PubMed ID: 26573234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
    Wang W; Hu S; Lu X; Young KH; Medeiros LJ
    Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.